Abstract Details
Teresa D. Gasalla, MD
(UCB Biosciences Inc)
PRESENTER |
Dr. Gasalla has received personal compensation for serving as an employee of UCB Biosciences Inc. Dr. Gasalla has stock in UCB Pharma. |
Elinor Ben-Menachem, MD, FAAN (Dept of Clinical Neuroscience) | Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic. |
No disclosure on file | |
No disclosure on file | |
Lori Jensen | No disclosure on file |
No disclosure on file | |
Marc De Backer, MD, FBCPM, MBA | No disclosure on file |
Melissa Brock (SCHWARZ BIOSCIENCES, Inc.) | No disclosure on file |
Victor Biton, MD (AEP) | Dr. Biton has nothing to disclose. |